BioTech 365

MARCH 12, 2021

Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. Amring Pharmaceuticals Inc. Enters into License and Development Agreement with Amzell B.V. –(BUSINESS WIRE)–Amring Pharmaceuticals Inc. BERWYN, Pa.–(BUSINESS

Licensing 52

Licensing Licensing Generic Pharmaceutical Development 52

XTalks

JUNE 8, 2022

Sandoz is a pioneering leader in generic pharmaceuticals and biosimilars, as Sandoz launched the world’s first biosimilar in Europe in 2006 and won the first biosimilar approval in the US in 2014. Among them are “ensuring equitable pricing, involving patients in treatment decisions and streamlining biosimilar development.”.

Generic Pharmaceutical 69

Generic Pharmaceutical Branding Production Medicine 69

The Pharma Data

MARCH 15, 2022

Agency Supports Development of Complex Generic Drug-Device Combination Product to Improve Competition and Access to More Affordable Medicines. The FDA regularly takes steps to help guide industry through the development process for generic drug products, including combination products, such as MDIs, that consist of a drug and a device.

FDA Approval 52

FDA Approval Generic Drugs Production Drugs 52

The Pharma Data

MAY 15, 2023

The Sandoz Board of Directors will have 10 members in total and 3 sub-committees: a Science, Innovation & Development Committee, a Human Capital & ESG Committee and an Audit, Risk & Compliance Committee. She is also a board member at BBI Solutions, a UK based diagnostic reagents and a Novo Holdings company.

Sales 40

Sales Production Doctors Doctor 40